75N93021D00012/to 75N93024F00001 fisher bioservices INC preclinical services for HIV therapeutics daids-car base award can 8470035 $147,227.00
Active Awarded Last action
- Contract number
- 75N93024F00001
- Awardee
-
Fisher Bioservices Inc. UEI LB4PCGLSJ9E6 Part of Thermo Electron Corporation
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $441,422
Award facts
- Contract value 48% obligated
-
- $441,422.00 Current, with exercised options
- $911,680.00 Potential, with all options
- Completion date 48% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $149,903 | |
| Exercise an Option | $144,292 | |
| Original award | $147,227 |
About this award
Fisher Bioservices Inc., a Clinical Trials Division subsidiary of Thermo Electron Corporation, was awarded a cost-plus-fixed-fee delivery order valued at $147,227 on December 15, 2023, under the Preclinical Services for HIV Therapeutics master contract vehicle administered by the National Institute of Allergy and Infectious Diseases (NIAID). This task order, designated as Task Area G, supports preclinical research services for HIV therapeutic development as part of NIAID's Division of AIDS (DAIDS) Clinical and Applied Research program. The contract carries a ceiling value of $911,680 and is scheduled for completion by December 14, 2029. The award includes no small business set-aside designation, reflecting Fisher Bioservices' status as an established federal contractor with significant experience in biorepository and scientific services.
Fisher Bioservices will perform work at its Potomac, Maryland facility, leveraging its core competencies in biospecimen storage, maintenance, distribution, and pharmaceutical handling services. The company has been a federal contractor since 2001 and maintains a substantial portfolio of Indefinite Delivery Contracts with NIH agencies, including a $100 million award for biospecimen repository services with the National Institute of Child Health and Human Development. This delivery order represents continued work under a larger preclinical services vehicle, enabling NIAID to access specialized scientific support infrastructure necessary for advancing HIV therapeutic research and development initiatives.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to Fisher Bioservices Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 15, 2023.
How much is contract 75N93024F00001 worth?
The government has obligated $441,422 on 75N93024F00001. Its potential value, with all options, is $911,680.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under 75N93021D00012, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award